Company Filing History:
Years Active: 2024
Title: Koutaro Ishibashi: Innovator in Biaryl Derivatives
Introduction
Koutaro Ishibashi is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmacology, particularly through his innovative work on biaryl derivatives. His research focuses on compounds that exhibit excellent tissue non-specific alkaline phosphatase inhibitory activity.
Latest Patents
Koutaro Ishibashi holds a patent for a biaryl derivative, which is a compound or a pharmacologically acceptable salt thereof. This invention is represented by a specific formula that includes various substituents, such as nitrogen atoms, C-C alkyl groups, and halogen atoms. The compound aims to provide therapeutic benefits by inhibiting alkaline phosphatase activity.
Career Highlights
Throughout his career, Koutaro Ishibashi has worked with prominent organizations, including Daiichi Sankyo Company, Limited and Sanford Burnham Prebys Medical Discovery Institute. His work in these institutions has allowed him to advance his research and contribute to the development of new pharmacological compounds.
Collaborations
Koutaro Ishibashi has collaborated with esteemed colleagues such as Takashi Tsuji and Yasunobu Kurosaki. These partnerships have fostered a collaborative environment that enhances innovation and research in the field of pharmacology.
Conclusion
Koutaro Ishibashi's contributions to the field of biaryl derivatives highlight his role as an innovator in pharmacology. His patent and collaborations reflect his commitment to advancing medical science and improving therapeutic options.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.